UNSPSC 85819302: Transfusion of autologous bone marrow into peripheral vein, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to transfusion of autologous bone marrow into peripheral vein, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 30233G0

UNSPSC 85819302 Transfusion of autologous bone marrow into peripheral vein, percutaneous approach is a Commodity code that shows no substantive alignment with recent state and local procurement activity. The six opportunities posted between July and September 2026 and tagged under this code span independent medical evaluations for pension disability determinations, surgical benefits carve-outs for employee health plans, occupational medical surveillance for ferry workers, emergency and specialty medical services for detained youth, pharmacy benefit management administration, and temporary health professional staffing — none of which involve autologous bone marrow transfusion procedures or related hematologic cellular therapies. The mismatch between the code's clinical scope and the nature of the solicitations suggests either systematic mis-tagging by posting jurisdictions or a misalignment between the taxonomy and how state and local procurement offices currently classify healthcare service contracts.

The issuing bodies span municipal retirement offices (City of Phoenix), cities (Long Beach), state transportation departments (Washington State Department of Transportation), county juvenile justice agencies (Harris County), county human resources and health systems (Collier County, Santa Clara County), reflecting a mix of benefits administration, occupational health, correctional healthcare, and public employee health programs. Geographic activity appears concentrated in the Southwest and West Coast (Arizona, California, Florida, Washington), though the posting dates and scope of work suggest these opportunities reflect benefits management, staffing, and medical surveillance service procurement rather than any procedure-specific clinical coding. No opportunities in the dataset involve bone marrow transfusions, regenerative medicine protocols, or related cellular therapies. Code users evaluating this Commodity should treat it as carrying minimal current market signal for state and local contracting activity.